article thumbnail

LabVantage Solutions Applauded by Frost & Sullivan for Its Industry-leading Flexible, Scalable, and Cost-effective LIMS Solutions

Frost & Sullivan

October 1, 2024 – Frost & Sullivan assessed the laboratory information management systems (LIMS) industry and, based on its findings, recognizes LabVantage Solutions with the 2024 Global Company of the Year Award. SAN ANTONIO, TX. LabVantage LIMS is an enterprise platform serving the full product life cycle.

article thumbnail

Best 30 Digital Marketing Agencies in Boston As Of 2024

Jake Jorgovan

Their service offers ongoing support and development, so your digital assets continue to evolve with your business, keeping you ahead in a competitive market.

Biotech 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Donna LaVoie to moderate at BIO webinar on Jan 18, “Signals from JPM Week for 2024 Business Development Planning”

LaVoie Health Science Blog

Donna LaVoie, President and CEO, will be moderating at the Biotechnology Innovation Organization (BIO) (link to page) on January 18th, between 2:00 and 3:00 pm ET.

article thumbnail

Public Relations and Marketing Intern 2024: Reflections on Boston, Biotech, and Beyond

LaVoie Health Science Blog

Here are the three insights I learned this summer and what I will take back to Norway as I complete my master’s degree: The complexity of biotechnology and pharmaceuticals I think most people agree that biotechnology and pharmaceuticals are complex industries, rooted in “hard science” technology.

Biotech 52
article thumbnail

Top 10 Strategic Imperatives Driving Innovation in AI-Enhanced Drug Discovery and Development

Frost & Sullivan

growth from 2023 to 2024. However, the pharma/biopharma industry overall shows stagnant R&D activity. Total R&D expenditure is approximately $276.81 billion, with a modest 2.5% This underscores the urgency to streamline drug development with newer technologies.

article thumbnail

Clinion Applauded by Frost & Sullivan for Enabling Interoperability and Continuity in Clinical Trials Management with its eClinical Solutions

Frost & Sullivan

July 9, 2024 – Frost & Sullivan recently assessed the integrated clinical trial optimization industry and, based on its findings, recognizes Clinion with the 2024 North American Technology Innovation Leadership Award. SAN ANTONIO, TX. The company is an innovator in the clinical trial and data management space.

article thumbnail

J.P Morgan 2024: Insights, Trends, and Tools for Maximizing your Experience

LaVoie Health Science Blog

Looking ahead to 2024, professionals worldwide are eagerly gearing up for one of the most anticipated events in the financial calendar—the J.P. Morgan 2024 experience. As you prepare for 2024, stay informed about the latest advancements in these fields to ensure your conversations and engagements are cutting edge.